http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108785310-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eda37409f26cb8e833ba67f2b1bc1fd5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
filingDate 2018-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c978ad179f18ca88089f16a83c1896b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff2716d24f93eba9b5a5691a2d305dfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90d612f6c9075a50b2fa75173ffdf741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a4abd720988dec1202c685e5e2a2bb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c5e33d783a81cd46bde502a2b282688
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff5e9dea3813484fe02ad6ce1ef0ea93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20ad0c55127ef24c7bf10c17e1fc5ed4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4acf5289eab78334ca889904024ca56a
publicationDate 2018-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108785310-A
titleOfInvention Application of the Vande Thani in the antitumor drug for preparing targeting EphB4
abstract The invention discloses application of the Vande Thani (dasatinib) in the antitumor drug for preparing targeting EphB4, belong to pharmaceutical technology field.The present invention is by the above application of experimental verification Vande Thani, and molecular docking method, SPR methods and MST are the experimental results showed that Vande Thani can interact with EphB4.EphB4 kinase assays show that Vande Thani can obviously inhibit EphB4 kinase activities.Significantly inhibit K562 Leukaemia, the proliferation of JLTRG, H9.Meanwhile Vande Thani significantly inhibits signaling molecule p-PI3K p85/p55, PI3K the p85 expression in the downstreams EphB4, lowers the phosphorylation level of MEK and ERK.Therefore, experimental result of the invention fully supports application of the Vande Thani in the tumour medicine of anti-leukemia medicine and targeting EphB4.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113398267-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113398267-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021184918-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115279411-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115279411-B
priorityDate 2018-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID554230
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16542
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID482154
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2011
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID461315
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3791
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID407170
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081361
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13846
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25589
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13728
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID535197
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30688
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2050
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID839585
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID796537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475039

Total number of triples: 50.